Zobrazeno 1 - 10
of 64
pro vyhledávání: '"L. Ziporen"'
Autor:
Douglas B. Cines, L. Ziporen, Mortimer Poncz, Gowthami M. Arepally, P. Sabnekar, Y Shoenfeld, Kwang Sook Park, Zhong Q. Li, Weiyi Liu, Thomas Kieber-Emmons
Publikováno v:
Blood. 92:3250-3259
Heparin-induced thrombocytopenia (HIT) is a potentially serious complication of heparin therapy. Antibodies to platelet factor 4 (PF4)/heparin complexes have been implicated in the pathogenesis of this disorder, but the antigenic epitope(s) on the pr
Autor:
Yair Levy, J. Cledes, Jacob George, Sylvie Polak-Charcon, Yehuda Shoenfeld, H Amital, Boris Gilburd, L. Ziporen, P Youinou
Publikováno v:
Human Antibodies. 7:91-96
Primary antiphospholipid syndrome (PAPS) is a recently recognized clinical entity encompassing the combination of thromboembolic phenomena, thrombocytopenia and recurrent abortions in the presence of antiphospholipid antibodies. We present a patient
Publikováno v:
Clinical rheumatology. 21(5)
The aim of this study was to evaluate the prevalence and the performance of lupus anticoagulant (LA) tests in a heterogeneous group of patients and to investigate the sociodemographic characteristics, patterns of referral, clinical manifestations and
Publikováno v:
Seminars in hematology. 36(1 Suppl 1)
Heparin-induced thrombocytopenia (HIT) occurs in 1% to 3% of patients receiving heparin and results from the development of antibodies that recognize heparin-platelet factor 4 (H-PF4) complexes that form on the surface of activated platelets and on t
Autor:
L, Ziporen, Y, Shoenfeld
Publikováno v:
Hematology and cell therapy. 40(5)
The availability of animal models of the APS has provided a lot of experimental data which might be considered in trying to unravel several questions concerning this complicated disease. The main clinical manifestations associated with this disorder
Autor:
L Ziporen, Y Shoenfeld
Publikováno v:
Lupus. 7
Several animal models for antiphospholipid syndrome (APS) have been reported in the literature. These experimental models have contributed significantly in resolving enigmas in this multisystemic disease. We, and others have previously shown the path
Autor:
L, Ziporen, Z Q, Li, K S, Park, P, Sabnekar, W Y, Liu, G, Arepally, Y, Shoenfeld, T, Kieber-Emmons, D B, Cines, M, Poncz
Publikováno v:
Blood. 92(9)
Heparin-induced thrombocytopenia (HIT) is a potentially serious complication of heparin therapy. Antibodies to platelet factor 4 (PF4)/heparin complexes have been implicated in the pathogenesis of this disorder, but the antigenic epitope(s) on the pr
Publikováno v:
Harefuah. 132(10)
Publikováno v:
Annales de medecine interne. 147
Anti-endothelial cell activity is partly due to antiphospholipid antibodies (aPLA) because: a) the two types of antibodies are present in patients with connective tissue diseases and cardiolipin-binding monoclonal antibodies recognize endothelial cel
Publikováno v:
Clinical and experimental rheumatology. 14(4)
The effects of the superantigens (SAgs) Staphylococcal Enterotoxin B (SEB), Toxic Shock Syndrome Toxin-1 (TSST-1) and Mycoplasma Arthritidis Mitogen (MAM) were examined on the induction and on the course of experimental SLE-like disease.Immunization